Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
Clinical trial NCT06978062 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06978062
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2028-09-11
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.